Tofacitinib Impurity 81 | CAS 2282653-53-4 - Request Quote
Tofacitinib Impurity 81
| SZ CAT No: | SZ-T010160 |
| CAS No | 2282653-53-4 |
| Mol.F. | C8H9ClN4 |
| Mol.Wt. | 196.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tofacitinib Impurity 81 is chemically 2-Chloro-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine. Tofacitinib Impurity 81 is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Impurity 81 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2282653-53-4
Purchase 2282653-53-4
Order 2282653-53-4
Enquire 2282653-53-4
price of 2282653-53-4
2282653-53-4 Supplier
2282653-53-4 Manufacturer
2282653-53-4 Exporter
buy high quality Tofacitinib Impurity 81
Purchase Tofacitinib Impurity 81
Tofacitinib Impurity 81 suppliers
Tofacitinib Impurity 81 manufacturers
Tofacitinib Impurity 81 price
Order Tofacitinib Impurity 81
Enquire Tofacitinib Impurity 81
Tofacitinib Impurity 81 cost
Tofacitinib Impurity 81 Supplier
Tofacitinib Impurity 81 Distributor
Tofacitinib Impurity 81 for Method Validation
Tofacitinib Reference Standard
Tofacitinib Impurity 81 for ANDA Filing
Tofacitinib Impurity 81 for Forced Degradation Studies
Tofacitinib Impurity 81 Identification Standards
Tofacitinib Impurity 81 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


